- Home
- AKTX vs SWVL Comparison
AKTX vs SWVL Comparison
Compare AKTX & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- SWVL
- Stock Information
- Founded
- AKTX N/A
- SWVL 2017
- Country
- AKTX United States
- SWVL United Arab Emirates
- Employees
- AKTX N/A
- SWVL N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- SWVL Business Services
- Sector
- AKTX Health Care
- SWVL Consumer Discretionary
- Exchange
- AKTX Nasdaq
- SWVL Nasdaq
- Market Cap
- AKTX 35.7M
- SWVL 40.6M
- IPO Year
- AKTX N/A
- SWVL N/A
- Fundamental
- Price
- AKTX $0.84
- SWVL $3.88
- Analyst Decision
- AKTX Strong Buy
- SWVL
- Analyst Count
- AKTX 1
- SWVL 0
- Target Price
- AKTX $5.00
- SWVL N/A
- AVG Volume (30 Days)
- AKTX 85.8K
- SWVL 17.0K
- Earning Date
- AKTX 08-13-2025
- SWVL 04-02-2025
- Dividend Yield
- AKTX N/A
- SWVL N/A
- EPS Growth
- AKTX N/A
- SWVL N/A
- EPS
- AKTX N/A
- SWVL N/A
- Revenue
- AKTX N/A
- SWVL $17,207,362.00
- Revenue This Year
- AKTX N/A
- SWVL N/A
- Revenue Next Year
- AKTX N/A
- SWVL N/A
- P/E Ratio
- AKTX N/A
- SWVL N/A
- Revenue Growth
- AKTX N/A
- SWVL N/A
- 52 Week Low
- AKTX $0.57
- SWVL $2.40
- 52 Week High
- AKTX $3.85
- SWVL $7.50
- Technical
- Relative Strength Index (RSI)
- AKTX 44.86
- SWVL 52.63
- Support Level
- AKTX $0.57
- SWVL $3.33
- Resistance Level
- AKTX $1.01
- SWVL $3.75
- Average True Range (ATR)
- AKTX 0.07
- SWVL 0.30
- MACD
- AKTX -0.00
- SWVL -0.00
- Stochastic Oscillator
- AKTX 63.51
- SWVL 67.31
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.